Skip to main content
. 2015 Dec 31;94(52):e2154. doi: 10.1097/MD.0000000000002154

FIGURE 3.

FIGURE 3

Overall survival curve of 24 BCLC B stage HCC patients after GSMs-TACE. The 6- and 12- month overall survival rates were 100% and 87.5%% respectively. BCLC = Barcelona Clinic Liver Cancer, GSMs-TACE = transarterial chemoembolization with gelatin sponge microparticles, HCC = hepatocellular carcinoma.